Cargando…
Reliability of Multiparametric Magnetic Resonance Imaging in Patients with a Previous Negative Biopsy: Comparison with Biopsy-Naïve Patients in the Detection of Clinically Significant Prostate Cancer
Background: Multiparametric magnetic resonance is an established imaging utilized in the diagnostic pathway of prostate cancer. The aim of this study is to evaluate the accuracy and reliability of multiparametric magnetic resonance imaging (mpMRI) in the detection of clinically significant prostate...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10253019/ https://www.ncbi.nlm.nih.gov/pubmed/37296791 http://dx.doi.org/10.3390/diagnostics13111939 |
_version_ | 1785056308099022848 |
---|---|
author | Barone, Biagio Napolitano, Luigi Calace, Francesco Paolo Del Biondo, Dario Napodano, Giorgio Grillo, Marco Reccia, Pasquale De Luca, Luigi Prezioso, Domenico Muto, Matteo Crocetto, Felice Ferro, Matteo |
author_facet | Barone, Biagio Napolitano, Luigi Calace, Francesco Paolo Del Biondo, Dario Napodano, Giorgio Grillo, Marco Reccia, Pasquale De Luca, Luigi Prezioso, Domenico Muto, Matteo Crocetto, Felice Ferro, Matteo |
author_sort | Barone, Biagio |
collection | PubMed |
description | Background: Multiparametric magnetic resonance is an established imaging utilized in the diagnostic pathway of prostate cancer. The aim of this study is to evaluate the accuracy and reliability of multiparametric magnetic resonance imaging (mpMRI) in the detection of clinically significant prostate cancer, defined as Gleason Score ≥ 4 + 3 or a maximum cancer core length 6 mm or longer, in patients with a previous negative biopsy. Methods: The study was conducted as a retrospective observational study at the University of Naples “Federico II”, Italy. Overall, 389 patients who underwent systematic and target prostate biopsy between January 2019 and July 2020 were involved and were divided into two groups: Group A, which included biopsy-naïve patients; Group B, which included re-biopsy patients. All mpMRI images were obtained using three Tesla instruments and were interpreted according to PIRADS (Prostate Imaging Reporting and Data System) version 2.0. Results: 327 patients were biopsy-naïve, while 62 belonged to the re-biopsy group. Both groups were comparable in terms of age, total PSA (prostate-specific antigen), and number of cores obtained at the biopsy. 2.2%, 8.8%, 36.1%, and 83.4% of, respectively, PIRADS 2, 3, 4, and 5 biopsy-naïve patients reported a clinically significant prostate cancer compared to 0%, 14.3%, 39%, and 66.6% of re-biopsy patients (p < 0.0001–p = 0.040). No difference was reported in terms of post-biopsy complications. Conclusions: mpMRI confirms its role as a reliable diagnostic tool prior to performing prostate biopsy in patients who underwent a previous negative biopsy, reporting a comparable detection rate of clinically significant prostate cancer. |
format | Online Article Text |
id | pubmed-10253019 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-102530192023-06-10 Reliability of Multiparametric Magnetic Resonance Imaging in Patients with a Previous Negative Biopsy: Comparison with Biopsy-Naïve Patients in the Detection of Clinically Significant Prostate Cancer Barone, Biagio Napolitano, Luigi Calace, Francesco Paolo Del Biondo, Dario Napodano, Giorgio Grillo, Marco Reccia, Pasquale De Luca, Luigi Prezioso, Domenico Muto, Matteo Crocetto, Felice Ferro, Matteo Diagnostics (Basel) Article Background: Multiparametric magnetic resonance is an established imaging utilized in the diagnostic pathway of prostate cancer. The aim of this study is to evaluate the accuracy and reliability of multiparametric magnetic resonance imaging (mpMRI) in the detection of clinically significant prostate cancer, defined as Gleason Score ≥ 4 + 3 or a maximum cancer core length 6 mm or longer, in patients with a previous negative biopsy. Methods: The study was conducted as a retrospective observational study at the University of Naples “Federico II”, Italy. Overall, 389 patients who underwent systematic and target prostate biopsy between January 2019 and July 2020 were involved and were divided into two groups: Group A, which included biopsy-naïve patients; Group B, which included re-biopsy patients. All mpMRI images were obtained using three Tesla instruments and were interpreted according to PIRADS (Prostate Imaging Reporting and Data System) version 2.0. Results: 327 patients were biopsy-naïve, while 62 belonged to the re-biopsy group. Both groups were comparable in terms of age, total PSA (prostate-specific antigen), and number of cores obtained at the biopsy. 2.2%, 8.8%, 36.1%, and 83.4% of, respectively, PIRADS 2, 3, 4, and 5 biopsy-naïve patients reported a clinically significant prostate cancer compared to 0%, 14.3%, 39%, and 66.6% of re-biopsy patients (p < 0.0001–p = 0.040). No difference was reported in terms of post-biopsy complications. Conclusions: mpMRI confirms its role as a reliable diagnostic tool prior to performing prostate biopsy in patients who underwent a previous negative biopsy, reporting a comparable detection rate of clinically significant prostate cancer. MDPI 2023-06-01 /pmc/articles/PMC10253019/ /pubmed/37296791 http://dx.doi.org/10.3390/diagnostics13111939 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Barone, Biagio Napolitano, Luigi Calace, Francesco Paolo Del Biondo, Dario Napodano, Giorgio Grillo, Marco Reccia, Pasquale De Luca, Luigi Prezioso, Domenico Muto, Matteo Crocetto, Felice Ferro, Matteo Reliability of Multiparametric Magnetic Resonance Imaging in Patients with a Previous Negative Biopsy: Comparison with Biopsy-Naïve Patients in the Detection of Clinically Significant Prostate Cancer |
title | Reliability of Multiparametric Magnetic Resonance Imaging in Patients with a Previous Negative Biopsy: Comparison with Biopsy-Naïve Patients in the Detection of Clinically Significant Prostate Cancer |
title_full | Reliability of Multiparametric Magnetic Resonance Imaging in Patients with a Previous Negative Biopsy: Comparison with Biopsy-Naïve Patients in the Detection of Clinically Significant Prostate Cancer |
title_fullStr | Reliability of Multiparametric Magnetic Resonance Imaging in Patients with a Previous Negative Biopsy: Comparison with Biopsy-Naïve Patients in the Detection of Clinically Significant Prostate Cancer |
title_full_unstemmed | Reliability of Multiparametric Magnetic Resonance Imaging in Patients with a Previous Negative Biopsy: Comparison with Biopsy-Naïve Patients in the Detection of Clinically Significant Prostate Cancer |
title_short | Reliability of Multiparametric Magnetic Resonance Imaging in Patients with a Previous Negative Biopsy: Comparison with Biopsy-Naïve Patients in the Detection of Clinically Significant Prostate Cancer |
title_sort | reliability of multiparametric magnetic resonance imaging in patients with a previous negative biopsy: comparison with biopsy-naïve patients in the detection of clinically significant prostate cancer |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10253019/ https://www.ncbi.nlm.nih.gov/pubmed/37296791 http://dx.doi.org/10.3390/diagnostics13111939 |
work_keys_str_mv | AT baronebiagio reliabilityofmultiparametricmagneticresonanceimaginginpatientswithapreviousnegativebiopsycomparisonwithbiopsynaivepatientsinthedetectionofclinicallysignificantprostatecancer AT napolitanoluigi reliabilityofmultiparametricmagneticresonanceimaginginpatientswithapreviousnegativebiopsycomparisonwithbiopsynaivepatientsinthedetectionofclinicallysignificantprostatecancer AT calacefrancescopaolo reliabilityofmultiparametricmagneticresonanceimaginginpatientswithapreviousnegativebiopsycomparisonwithbiopsynaivepatientsinthedetectionofclinicallysignificantprostatecancer AT delbiondodario reliabilityofmultiparametricmagneticresonanceimaginginpatientswithapreviousnegativebiopsycomparisonwithbiopsynaivepatientsinthedetectionofclinicallysignificantprostatecancer AT napodanogiorgio reliabilityofmultiparametricmagneticresonanceimaginginpatientswithapreviousnegativebiopsycomparisonwithbiopsynaivepatientsinthedetectionofclinicallysignificantprostatecancer AT grillomarco reliabilityofmultiparametricmagneticresonanceimaginginpatientswithapreviousnegativebiopsycomparisonwithbiopsynaivepatientsinthedetectionofclinicallysignificantprostatecancer AT recciapasquale reliabilityofmultiparametricmagneticresonanceimaginginpatientswithapreviousnegativebiopsycomparisonwithbiopsynaivepatientsinthedetectionofclinicallysignificantprostatecancer AT delucaluigi reliabilityofmultiparametricmagneticresonanceimaginginpatientswithapreviousnegativebiopsycomparisonwithbiopsynaivepatientsinthedetectionofclinicallysignificantprostatecancer AT preziosodomenico reliabilityofmultiparametricmagneticresonanceimaginginpatientswithapreviousnegativebiopsycomparisonwithbiopsynaivepatientsinthedetectionofclinicallysignificantprostatecancer AT mutomatteo reliabilityofmultiparametricmagneticresonanceimaginginpatientswithapreviousnegativebiopsycomparisonwithbiopsynaivepatientsinthedetectionofclinicallysignificantprostatecancer AT crocettofelice reliabilityofmultiparametricmagneticresonanceimaginginpatientswithapreviousnegativebiopsycomparisonwithbiopsynaivepatientsinthedetectionofclinicallysignificantprostatecancer AT ferromatteo reliabilityofmultiparametricmagneticresonanceimaginginpatientswithapreviousnegativebiopsycomparisonwithbiopsynaivepatientsinthedetectionofclinicallysignificantprostatecancer |